Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and stabilizing plasma NfL levels FDA feedback from recent ...

Bio-Techne Reorganizes Brand To Link Research Spatial And Diagnostics Workflows

Bio-Techne Corporation (NasdaqGS:TECH) is rolling out a new brand architecture centered on three portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The updated structure ...

Opna Bio Announces Fast Track Designation Granted to OPN-6602 for the Treatment of Multiple Myeloma

OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-s ...
foxbangor.com

MDI Bio Lab secures funding to strengthen Maine's role in regeneration science

The MDI Biological Laboratory in Bar Harbor is a leader in regeneration science and medicine. The institution recently ...
St. Louis Magazine

How Peptyde Bio’s purchase is leading to good things for Danforth Center—and St. Louis

Invaio Sciences acquisition of the startup has helped put St. Louis’ bio and plant sciences ecosystem on the map in Boston.